Guidance on the use of paclitaxel in the treatment of ovarian cancer

  • Technology appraisal guidance
  • TA55
  • Published: 
  • Last updated: 
Download guidance (PDF)

6 Further research

6.1

Research would be beneficial to examine the following aspects of effectiveness and cost effectiveness of paclitaxel:

  • whether paclitaxel/platinum combination therapy is of particular benefit to identifiable clinical sub-groups

  • the optimal sequencing of paclitaxel therapy with other ovarian chemotherapy compounds – that is, paclitaxel/platinum combination vs platinum followed by paclitaxel in sequence.